These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6721467)

  • 1. Pharmacokinetics and tolerance of cefuroxime axetil in volunteers during repeated dosing.
    Sommers DK; Van Wyk M; Williams PE; Harding SM
    Antimicrob Agents Chemother; 1984 Mar; 25(3):344-7. PubMed ID: 6721467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers.
    Harding SM; Williams PE; Ayrton J
    Antimicrob Agents Chemother; 1984 Jan; 25(1):78-82. PubMed ID: 6703686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil.
    Sommers DK; van Wyk M; Moncrieff J; Schoeman HS
    Br J Clin Pharmacol; 1984 Oct; 18(4):535-9. PubMed ID: 6091711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection.
    Adams DH; Wood MJ; Farrell ID; Fox C; Ball AP
    J Antimicrob Chemother; 1985 Sep; 16(3):359-66. PubMed ID: 4055543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of pivmecillinam.
    Parsons RL; Hossack GA; Paddock GM
    Br J Clin Pharmacol; 1977 Jun; 4(3):267-73. PubMed ID: 197981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of bacmecillinam and pivmecillinam in volunteers.
    Josefsson K; Bergan T; Magni L; Pring BG; Westerlund D
    Eur J Clin Pharmacol; 1982; 23(3):249-52. PubMed ID: 6293834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food.
    Williams PE; Harding SM
    J Antimicrob Chemother; 1984 Feb; 13(2):191-6. PubMed ID: 6706890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral cefuroxime axetil compared with oral ampicillin in treating acute uncomplicated gonorrhoea.
    Wanas TM; Williams PE
    Genitourin Med; 1986 Aug; 62(4):221-3. PubMed ID: 3733084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations and penetration into prostate of mecillinam and ampicillin.
    Jeppesen N; Frimodt-Møller C
    Curr Med Res Opin; 1984; 9(3):213-8. PubMed ID: 6499514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dose and food on the bioavailability of cefuroxime axetil.
    Finn A; Straughn A; Meyer M; Chubb J
    Biopharm Drug Dispos; 1987; 8(6):519-26. PubMed ID: 3427209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of oral treatment of uncomplicated urogenital and rectal gonorrhoea with cefuroxime axetil ester or clavulanic acid potentiated amoxycillin (Augmentin).
    Schift R; van Ulsen J; Ansink-Schipper MC; van Joost T; Michel MF; Woudstra RK; Stolz E
    Genitourin Med; 1986 Oct; 62(5):313-7. PubMed ID: 3533755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.
    Nix DE; Symonds WT; Hyatt JM; Wilton JH; Teal MA; Reidenberg P; Affrime MB
    Pharmacotherapy; 1997; 17(1):121-5. PubMed ID: 9017772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative investigations on the bioavailability of cefuroxime axetil.
    Kees F; Lukassek U; Naber KG; Grobecker H
    Arzneimittelforschung; 1991 Aug; 41(8):843-6. PubMed ID: 1781808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of pivampicillin and pivmecillinam versus pivampicillin alone in the treatment of acute pyelonephritis.
    Eriksson S; Zbornik J; Dahnsjö H; Erlanson P; Kahlmeter O; Fritz H; Bauer CA
    Scand J Infect Dis; 1986; 18(5):431-8. PubMed ID: 3535049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state.
    Stoeckel K; Harell M; Dan M
    Antimicrob Agents Chemother; 1996 Mar; 40(3):780-3. PubMed ID: 8851611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of two types of Indian breakfast on bioavailability of cefuroxime axetil.
    Vasu S; Adithan C; Shashindran CH; Asad M; Koumaravelou K; Topno I
    Indian J Med Res; 2000 Sep; 112():104-8. PubMed ID: 11094856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin.
    Williams KJ; Hebblethwaite EM; Brown GW; Cox DM; Plested SJ
    Drugs Exp Clin Res; 1987; 13(2):95-9. PubMed ID: 3556123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the safety of cefuroxime axetil during six months oral administration to beagle dogs.
    Spurling NW; Harcourt RA; Hyde JJ
    J Toxicol Sci; 1986 Nov; 11(4):237-77. PubMed ID: 3820342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fixed combination of pivmecillinam and pivampicillin in complicated urinary tract infections. A double-blind comparison with pivmecillinam.
    Igesund A; Vorland L
    Scand J Infect Dis; 1982; 14(2):159-60. PubMed ID: 6285450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bactericidal activity of cefuroxime axetil.
    Ginsburg CM; McCracken GH; Petruska M; Olson K
    Antimicrob Agents Chemother; 1985 Oct; 28(4):504-7. PubMed ID: 3878129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.